Chinese Traditional and Herbal Drugs
|
2025, 56(8): 2662-2677
Research on improvement of quality markers for Bitongning Capsules based on strategy with “chinmedomics - targeted protein analysis”
Full
LIU Shaobo, YAO Longyu, ZHA Xin, CHEN Yan, TAO Ling, YAN Guangli, KONG Ling, SHEN Xiangchun, WANG Xijun
Affiliations
doi: 10.7501/j.issn.0253-2670.2025.08.004
Outline
Objective To conduct an in-depth exploration of quality markers for Bitongning Capsules (BC, 痹痛宁胶囊) using a strategy integrating formula-pattern metabolomics and targeted protein analysis, thereby laying the foundation for enhancing its quality standards. Methods Centered on the clinical indications of BC, a rat model of bone and joint disease with wind-cold-dampness arthralgia syndrome was established. Non-targeted metabolomics analysis was performed to identify blood metabolic markers associated with disease progression. Under the premise of drug efficacy, key metabolic profiles regulated by BC in treating bone and joint diseases under this syndrome were determined. Bioinformatics methods were employed to extract core protein targets within these metabolic profiles. Molecular docking analysis was conducted between these targets and the direct bioactive components of BC in vivo to identify pharmacodynamic material bases. Combined with the “five-principle” system for quality markers (effectiveness, measurability, traceability, efficacy correlation, and specificity), the quality markers were comprehensively identified. Results Metabolomics analysis revealed 30 small-molecule metabolites, including 1-methylnicotinamide, D-glutamine, and linolenic acid. The α-linolenic acid metabolism pathway was identified as the key regulatory pathway for BC in treating bone and joint diseases under wind-cold-dampness arthralgia syndrome. Six core protein targets (PLA2G2A, PLA2G2F, PLA2G2D, etc.) were extracted from this pathway. Additionally, 22 direct bioactive components of BC in vivo were screened. Molecular docking analysis confirmed that isoliquiritin, dihydrokaempferol, and 5,3',4'-trihydroxyflavone met the “five-principle” criteria for quality markers. Conclusion The components isoliquiritin, dihydrokaempferol, and 5,3',4'-trihydroxyflavone fulfill the principles of effectiveness, measurability, traceability, efficacy correlation, and specificity, demonstrating potential as quality markers for BC.
Bitongning Capsules
/
quality marker
/
chinmedomics
/
osteoarthropathy
/
pharmacodynamic material basis
/
wind-cold-dampness arthralgia syndrome
/
bioinformatics
/
molecular docking
/
α-linolenic acid
/
testability
/
traceability
/
efficacy relevance
/
specificity
/
isoliquiritin
/
dihydrokaempferol
/
5,3′,4′-trihydroxyflavone
刘绍博, 姚龙宇, 查鑫, 陈妍, 陶玲, 闫广利, 孔玲, 沈祥春, 王喜军.
基于方证代谢组学联合靶向蛋白分析策略的痹痛宁胶囊质量标志物(Q-Marker)研究.
中草药,
2025
, 56
(8)
: 2662
-2677
.
DOI: 10.7501/j.issn.0253-2670.2025.08.004
LIU Shaobo, YAO Longyu, ZHA Xin, CHEN Yan, TAO Ling, YAN Guangli, KONG Ling, SHEN Xiangchun, WANG Xijun.
Research on improvement of quality markers for Bitongning Capsules based on strategy with “chinmedomics - targeted protein analysis”[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(8)
: 2662
-2677
.
DOI: 10.7501/j.issn.0253-2670.2025.08.004
Year 2025 volume 56 Issue 8
51
9
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.08.004
- Receive Date:2024-12-29
- Online Date:2026-11-13